Price T Rowe Associates Inc Timber Pharmaceuticals, Inc. Transaction History

Price T Rowe Associates Inc

  • $836 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$0.38 - $0.89 $51,186 - $119,883
-134,700 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$0.89 - $1.18 $58,473 - $77,526
65,700 Added 95.22%
134,700 $123,000
Q2 2021

Aug 16, 2021
BUY
$1.06 - $2.25 $73,140 - $155,250
69,000 New
69,000 $84,000

About Timber Pharmaceuticals, Inc.

TMBR Quotes by TradingView
  • Ticker TMBR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,524,992
  • Description
  • Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...
More about TMBR
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email